National Institute of Virology (NIV) Current Affairs, GK & News

What is Kyasanur Forest Disease?

Recently, researchers found a new point-of-care test to be highly sensitive for rapid diagnosis of Kyasanur forest disease (KFD) which is emerging as a new public health problem & challenge in India. Point-of-care tests The point-of-care tests has been developed by ICMR-National Institute of Virology. It will be beneficial to diagnose KFD which is also ..

Month: 

Category: 

Topics: 

Triple Mutant Variant

As India is struggling to battle COVID-19 crisis, a triple mutant variant strain of COVID-19 has emerged as a fresh threat. It is also called the “Bengal Variant”. The triple mutant variant has been identified in West Bengal, Maharashtra, Delhi and Chhattisgarh. What is Triple Mutant Variant? The Triple Mutant Variant has evolved from double ..

Month: 

Category: 

Topics: 

WHO: UK Variant of COVID-19 in 41 countries

The World Health Organisation recently announced that the United Kingdom covid-19 variant has been detected in more than 41 countries. The VOC-202012/01 the was first detected in South Africa. This variant is 70% more transmissible than the other covid-19 mutants. Has VOC-202012/01 reached India? Yes. Around 38 people have been found infected with the mutant. It has ..

Month: 

Category: 

Topics: 

COVID-19: ICMR develops “Purified Antisera” as treatment

The Indian Council of Medical Research along with Hyderabad based Biological E has developed “Purified Antisera”. The antiserum has been obtained from animals. This is to be used as a prophylaxis and treatment for COVID-19. Highlights The new therapy works just like that of plasma therapy. But here the plasma is obtained from animals. Antiserum ..

Month: 

Category: 

Topics: 

Dr. Dangs Lab to Partner with Bharat Biotech for Human Trials of Covaxin

The Delhi-based private laboratory, Dr Dangs Lab, has announced that they have been selected as the central laboratory for human clinical trials of Covaxin, which is touted as the first-ever indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, Pune. The human clinical trial ..

Month: 

Category: 

Topics: